MedPlus Listed
India's largest listed retail pharmacy chain by store count, operating an omnichannel network of pharmacy stores plus online pharmacy, lab-test and eyewear services. Incorporated as MedPlus Health Services Private Limited on November 30, 2006 in Hyderabad by Gangadi Madhukar Reddy; converted to a public limited company in 2021 and listed on the NSE/BSE that December.
Valuation
Returns
Per share
Growth · year on year
Ownership
Price and ratios are compiled from the exchange and third-party market data, cached and refreshed through the day — they are not Atlas facts and are not investment advice. Where a ratio is computed on more than one basis (for example standalone versus trailing-twelve-month), each is shown separately rather than averaged into a single number.
How this score is calculated
| Measure | Value | Scores | Source |
|---|---|---|---|
| P/E What the market pays for each rupee of earnings. Lower is cheaper — but a low P/E can also mean the market expects earnings to fall. Computed on a different basis this reads 122.94, which would score 0/100. Scored on the figure shown. |
26.15 | 50/100 | BSE |
| P/B Price against book value. Most meaningful for banks and asset-heavy businesses; software and consumer brands trade high here for good reasons. |
6.15 | 25/100 | Market data |
| ROE Return on equity — profit generated per rupee of shareholder capital. Sustained high ROE is the clearest single marker of a good business. |
4.95 | 0/100 | Market data |
| ROCE Return on capital employed — the same idea including debt, so it is harder to flatter with leverage. |
7.16 | 25/100 | Market data |
| Profit growth Year-on-year growth in profit. Weighted above sales growth because profitable growth is the harder thing to do. |
54.73 | 100/100 | Market data |
| Sales growth Year-on-year growth in revenue. |
20.68 | 100/100 | Market data |
| Promoter holding How much of the company its founders and controlling group still own. Higher usually means their money moves with yours. |
40.19 | 75/100 | Market data |
The Atlas Score is our own arithmetic on the published figures above — nothing is hidden and nothing is bought in. It weighs quality and growth at 30% each, valuation at 25% and ownership at 15%, scoring each measure against fixed bands. Growth blends third-party market data with the fiscal-year figures we file and cite ourselves, so a company we have researched more deeply scores on richer evidence. A measure we could not fetch is left out of the average rather than counted as a zero. It is a summary of the numbers, not a recommendation, not a price target, and not advice about your circumstances.
MedPlus: Funding Rounds
| Date | Round | Amount | Investors | Source |
|---|---|---|---|---|
| 23 Dec 2021 | IPO | ₹600 Cr fresh issue | source | |
| 2021 ~ | Private Equity | ₹6.56 Bn (~24.58% stake, primary + secondary) | Lavender Rose | source |
| 2021 ~ | Series C2 | ₹222.10 Mn (Series C2 CCPS) | PI Opportunities Fund - I | source |
| 2019 ~ | Private Equity | Undisclosed | PI Opportunities Fund - I | source |
| 10 Nov 2014 | Private Equity | ₹12.23 Cr (12,233,118 redeemable preference shares @ ₹10 face value) | Indiaventure Trust – Fund I Indiaventure Trust – Fund II M V Satyanarayana Raju Merlin Holdings Private Limited TVS Shriram Growth Fund I | source |
| 4 Mar 2011 | Private Equity | ₹60 Cr (16,173 equity shares @ ₹37,098.18/share) | TVS Shriram Growth Fund I | source |
| 2007 ~ | Series B | ₹800M + ₹226.33M + $5M (~$29.8M combined) | Kalaari Capital Peepul Capital Pharmaceutica Ventures Limited | source |
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 25 Sep 2019 | MedPlus | Kalyani Meditimes Private Limited | $71K | source |
| 14 Aug 2018 | MedPlus | Ritemed | Undisclosed | source |
| 20 Sep 2014 | MedPlus | Shri Banashankari Pharma Private Limited | $18K | source |
| 15 Sep 2014 | MedPlus | Sidson Pharma Distributors Private Limited | $83.6K | source |
| 5 Jan 2012 | MedPlus | Deccan Medisales Private Limited | $58K | source |
News on MedPlus
No coverage of MedPlus linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on MedPlus
Who founded MedPlus?
MedPlus was founded by Gangadi Madhukar Reddy in 2006.
How much funding has MedPlus raised?
MedPlus has raised $216.25 Mn across 7 tracked funding round(s), most recently on 2021-12-23. Figures are compiled from cited public sources.
Who are the investors in MedPlus?
Investors in MedPlus include Lavender Rose, PI Opportunities Fund - I.
What does MedPlus do?
India's largest listed retail pharmacy chain by store count, operating an omnichannel network of pharmacy stores plus online pharmacy, lab-test and eyewear services. Incorporated as MedPlus Health Services Private Limited on November 30, 2006 in Hyderabad by Gangadi Madhukar Reddy; converted to a public limited…
Where is MedPlus headquartered?
MedPlus is headquartered in Hyderabad, Telangana, India.
What is MedPlus's business model?
MedPlus's core value proposition centers on Genuine medicines, reduced supply-chain inefficiency.
How does MedPlus make money?
MedPlus's cited revenue streams include Branded & private-label pharmaceutical product sales, Diagnostics testing revenue, Franchisee & B2B wholesale revenue, MedPlus Advantage membership fees.